These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38183891)

  • 1. Novel computerized measure of apathy associates with care partner burden and instrumental activities of daily living in Parkinson's disease.
    Liu J; Massimo L; McMillan CT; Dahodwala N
    Parkinsonism Relat Disord; 2024 Mar; 120():105983. PubMed ID: 38183891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized assessment of goal-directed behavior in Parkinson's disease.
    Fitts W; Massimo L; Lim N; Grossman M; Dahodwala N
    J Clin Exp Neuropsychol; 2016 Nov; 38(9):1015-25. PubMed ID: 27270271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.
    Brennan L; Siderowf A; Rubright JD; Rick J; Dahodwala N; Duda JE; Hurtig H; Stern M; Xie SX; Rennert L; Karlawish J; Shea JA; Trojanowski JQ; Weintraub D
    Parkinsonism Relat Disord; 2016 Apr; 25():21-6. PubMed ID: 26923524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy in Frontotemporal Degeneration: Neuroanatomical Evidence of Impaired Goal-directed Behavior.
    Massimo L; Powers JP; Evans LK; McMillan CT; Rascovsky K; Eslinger P; Ersek M; Irwin DJ; Grossman M
    Front Hum Neurosci; 2015; 9():611. PubMed ID: 26617508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach.
    Macchi ZA; Koljack CE; Miyasaki JM; Katz M; Galifianakis N; Prizer LP; Sillau SH; Kluger BM
    Ann Palliat Med; 2020 Feb; 9(Suppl 1):S24-S33. PubMed ID: 31735048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial.
    Fernandez HH; Weintraub D; Macklin E; Litvan I; Schwarzschild MA; Eberling J; Videnovic A; Kenney CJ;
    Parkinsonism Relat Disord; 2023 Sep; 114():105511. PubMed ID: 37532622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual Group Music Therapy for Apathy in Parkinson's Disease: A Pilot Study.
    Shah-Zamora D; Anderson S; Barton B; Fleisher JE
    J Geriatr Psychiatry Neurol; 2024 Jan; 37(1):49-60. PubMed ID: 37201184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
    Hauser RA; Slawek J; Barone P; Dohin E; Surmann E; Asgharnejad M; Bauer L
    BMC Neurol; 2016 Jun; 16():90. PubMed ID: 27267880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.
    Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A
    J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease.
    D'Iorio A; Vitale C; Piscopo F; Baiano C; Falanga AP; Longo K; Amboni M; Barone P; Santangelo G
    Parkinsonism Relat Disord; 2017 Oct; 43():114-117. PubMed ID: 28797564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating subtypes of apathy to improve person-centered care in frontotemporal degeneration.
    Massimo L; Evans LK
    J Gerontol Nurs; 2014 Oct; 40(10):58-65. PubMed ID: 25199154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy in individuals with Parkinson's disease associated with mild cognitive impairment. A neuropsychological investigation.
    Costa A; Peppe A; Zabberoni S; Scalici F; Caltagirone C; Carlesimo GA
    Neuropsychologia; 2018 Sep; 118(Pt B):4-11. PubMed ID: 29787739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkinson's Active Living (PAL) Program.
    Butterfield LC; Cimino CR; Salazar R; Sanchez-Ramos J; Bowers D; Okun MS
    J Geriatr Psychiatry Neurol; 2017 Jan; 30(1):11-25. PubMed ID: 28248557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?
    Loued-Khenissi L; Preuschoff K
    Curr Opin Neurol; 2015 Aug; 28(4):344-50. PubMed ID: 26110801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between emotional apathy and motor symptoms, sleep and cognitive function in patients with early Parkinson's disease].
    Chao JY; Xiong KP; Zhuang S; Zhang JR; Huang JY; Li J; Mao CJ; Wu HH; Wang JY; Liu CF
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2792-2797. PubMed ID: 34551496
    [No Abstract]   [Full Text] [Related]  

  • 17. Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.
    Martin GP; McDonald KR; Allsop D; Diggle PJ; Leroi I
    J Neurol; 2020 Jan; 267(1):214-227. PubMed ID: 31616991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of burden in caregivers of people with Alzheimer's disease using self-report and supervision hours.
    Haro JM; Kahle-Wrobleski K; Bruno G; Belger M; Dell'Agnello G; Dodel R; Jones RW; Reed CC; Vellas B; Wimo A; Argimon JM
    J Nutr Health Aging; 2014 Jul; 18(7):677-84. PubMed ID: 25226106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.
    Deck BL; Xie SX; Choi G; Rick J; Siderowf A; Rudovsky S; Chen-Plotkin A; Duda JE; Morley JF; Dahodwala N; Trojanowski JQ; Weintraub D
    Mov Disord Clin Pract; 2019 Jul; 6(6):440-445. PubMed ID: 31392244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
    Weintraub D; Marras C; Amara A; Anderson KE; Chahine LM; Eberly S; Hosamath A; Kinel D; Mantri S; Mathur S; Oakes D; Purks JL; Standaert DG; Shoulson I; Arbatti L
    Mov Disord; 2024 Apr; 39(4):706-714. PubMed ID: 38318953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.